微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.47% | -70.63% | -10.51% | 75/132 | 0.36% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 2.76% | -56.54% | -17.61% | 60/132 | 1.85% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 3.35% | -25.56% | -65.25% | 16/132 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 9.64% | 4.33% | 14.63% | 32/132 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 8.41% | -6.45% | 32.44% | 27/132 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 6.35% | -5.08% | 41.11% | 22/132 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 4.5% | -1.75% | -51.3% | 11/132 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.24% | -67.51% | 2.78% | 37/132 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.99% | -71.51% | 34.38% | 32/132 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 6.69% | -77.1% | 46.07% | 28/132 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.58% | -80.68% | -83.9% | 19/132 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 28.44% | 59.24% | -9.86% | 14/132 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 31.55% | 55.8% | 7.97% | 13/132 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 29.22% | 78.61% | 23.29% | 10/132 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 23.7% | 346.33% | 32.7% | 7/132 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 17.86% | -23.68% | -11.8% | 44/132 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 20.25% | -11.38% | 23.78% | 25/132 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 16.36% | -10.36% | 208.1% | 19/132 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 5.31% | 23.49% | -77.31% | 31/132 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 23.4% | 30.8% | 2.41% | 43/132 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 22.85% | 61.26% | 25.21% | 21/132 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 18.25% | 92.71% | 324.42% | 24/132 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 4.3% | 16.85% | -75.96% | 21/132 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 17.89% | 6.36% | 26.25% | 46/132 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 14.17% | -13.01% | 49.63% | 16/132 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 9.47% | -14.14% | 157.34% | 16/132 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.68% | -29.37% | -78.12% | 15/132 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 16.82% | -12.44% | 3.25% | 44/132 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 16.29% | 0.74% | 47.69% | 7/132 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 11.03% | 12.78% | 111.71% | 5/132 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 5.21% | 30.58% | -72.88% | 7/132 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 19.21% | 20.51% | 18.8% | 28/132 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 16.17% | 8.67% | 65.34% | 8/132 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 9.78% | 2.19% | 145.11% | 12/132 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.99% | 9.02% | -74.97% | 8/132 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 15.94% | -20.02% | 7.12% | 32/132 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 14.88% | 44.05% | 55.49% | 7/132 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 9.57% | -10.39% | 161.48% | 12/132 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | 3.66% | -63.58% | -81.64% | 5/132 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | 19.93% | -23.67% | 92.93% | 16/132 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | 10.33% | 2% | -3.28% | 10/132 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | 10.68% | 2% | 6.27% | 11/132 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | 10.05% | 2% | -61.51% | 3/132 | 3.2% | 中源协和 | 14.44% | 行业排名> |